{{Rsnum
|rsid=3769827
|Gene=CASP8
|Chromosome=2
|position=201237962
|Orientation=minus
|GMAF=0.3499
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=CASP8
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 19.5 | 46.0 | 34.5
| HCB | 2.2 | 36.8 | 61.0
| JPT | 2.7 | 24.8 | 72.6
| YRI | 6.8 | 49.0 | 44.2
| ASW | 10.5 | 49.1 | 40.4
| CHB | 2.2 | 36.8 | 61.0
| CHD | 4.6 | 36.1 | 59.3
| GIH | 5.0 | 30.7 | 64.4
| LWK | 8.2 | 38.2 | 53.6
| MEX | 13.8 | 62.1 | 24.1
| MKK | 7.1 | 36.8 | 56.1
| TSI | 19.6 | 49.0 | 31.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=21714991
|Title=Polymorphisms in the CASP8 gene and the risk of epithelial ovarian cancer
}}

{{PMID|19531679|OA=1
}} Polymorphisms and haplotypes in the caspase-3, caspase-7, and caspase-8 genes and risk for endometrial cancer: a population-based, case-control study in a Chinese population.

{{PMID Auto
|PMID=22843554
|Title=Association between CASP8 and CASP10 polymorphisms and toxicity outcomes with platinum-based chemotherapy in Chinese patients with non-small cell lung cancer.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}